GE HealthCare Technologies Inc. (GEHC)
About GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $20.6B
- Net income
- $2.1B
- Total assets
- $36.9B
- Market cap
- $29.4B
- Gross margin
- 40.0%
- Operating margin
- 13.4%
- Net margin
- 10.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $20.6B
- Cost of revenue
- $12.4B
- Gross profit
- $8.2B
- Operating expenses
- $5.5B
- Operating income
- $2.8B
- Income tax
- $614.0M
- Net income
- $2.2B
- EPS (basic)
- $4.56
- EPS (diluted)
- $4.55
Balance sheet
- Total assets
- $36.9B
- Current assets
- $12.5B
- Total liabilities
- $26.3B
- Current liabilities
- $9.1B
- Shareholders’ equity
- $10.4B
Cash flow
- Operating cash flow
- $2.0B
- Investing cash flow
- -$1.0B
- Financing cash flow
- $617.0M
- Net cash flow
- $1.6B
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $29.4B
- P/E ratio
- 13.3
- EPS (diluted)
- $4.55
- Dividend yield
- 0.23%
- Shares outstanding
- 485.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 15, 2022
GE HealthCare Technologies Inc. (GEHC) Stock Price
- Profitable — net income of $2.1B in FY2025.
- Revenue grew 5% from FY2023 to FY2025.
- Gross margin of 40.0%, net margin 10.4%.
- Trading 31% below its 52-week high.
- Pays a dividend yielding about 0.23% annually.
- Valued at a price-to-earnings (P/E) ratio of 13.3.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review GE HealthCare Technologies Inc..
Write a review
News about GE HealthCare Technologies Inc.
News & sentiment via Polygon.io
GE HealthCare Technologies Inc.: frequently asked questions
Is GE HealthCare Technologies Inc. an American company?
Yes — GE HealthCare Technologies Inc. is an American company headquartered in Chicago, Illinois. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is GE HealthCare Technologies Inc. headquartered?
GE HealthCare Technologies Inc. is headquartered in Chicago, Illinois, United States.
Is GE HealthCare Technologies Inc. publicly traded?
Yes — GE HealthCare Technologies Inc. is a publicly traded company. Its stock trades under the ticker symbol GEHC on the NASDAQ.
What does GE HealthCare Technologies Inc. do?
GE HealthCare Technologies Inc. is an American Medical Devices company in the Health & Beauty sector.
